(Updated - August 10, 2026 1:16 PM EDT)

Guggenheim analyst Yatin Suneja downgraded Sionna Therapeutics (NASDAQ: SION) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades